Study Details

Back
Study ID 79051/ODS1
Study Title YM905 Phase II Study - Dose Finding Study(Original language of CSR synopsis is Japanese.)
Clinicaltrials.gov Identifier Not Applicable
Compound Name YM905 / solifenacin succinate
Medical Indication or Disease Overactive bladder
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 03-Aug-2001
Study Completion Date 05-Jun-2002
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS